aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
D&D Pharmatech is a global biotech company focused on developing innovative therapies for fibrotic diseases, Alzheimer's, and Parkinson's. The company targets myofibroblasts to cure chronic conditions, aiming to transform patient care through cutting-edge research and development.
D&D Pharmatech has made significant strides in the biotech industry, contributing to advancements in treating complex diseases. The company conducts its business in Korea, leveraging a strong research foundation to impact global health positively.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Drug Development
Technology
Biotech
Model Types
Software, Research
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was D&D Pharmatech founded?
D&D Pharmatech was founded in 2014.
Where is D&D Pharmatech’s headquarters located?
D&D Pharmatech’s headquarters is located in Gaithersburg, MD, US.
When was D&D Pharmatech’s last funding round?
D&D Pharmatech’s most recent funding round was for $51M (USD) in October 2021.
How many employees does D&D Pharmatech have?
D&D Pharmatech has 11 employees as of Feb 5, 2024.
How much has D&D Pharmatech raised to-date?
As of July 05, 2023, D&D Pharmatech has raised a total of $233.6M (USD) since Oct 19, 2021.
Add Comparison
Total Raised to Date
$233.6M
USD
Last Update Oct 19, 2021
Last Deal Details
$51M
USD
Oct 19, 2021
Series C
Total Employees Over Time
11
As of Feb 2024
D&D Pharmatech Address
704 Quince Orchard Road Quince Orchard Road
Suite 320
Gaithersburg,
Maryland
20878
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts